Channel Medsystems was founded to bring innovation to the delivery of women’s healthcare.
The Cerene device is Channel’s flagship PMA approved product and offers a differentiated treatment option for women suffering from heavy menstrual bleeding. Cerene’s safety and effectiveness is supported by significant long-term clinical data and can be performed minimally invasively in the office setting without the need for IV sedation / anesthesia. Channel’s unique value proposition positions the Company as a leader in the large and growing Women’s Health market.
